Aerocrine: Aerocrine signs distribution agreement with third largest chinese … – The Herald | HeraldOnline.com

Aerocrine: Aerocrine signs distribution agreement with third largest chinese
The Herald | HeraldOnline.com
The agreement, effective as of September 24, 2012, gives SPH exclusive rights for import and non-exclusive rights for distribution of Aerocrine's instrument NIOX MINO® and test kits, used for diagnosing and monitoring patients with asthma, on the

and more »

View full post on asthma – Google News

PPD and Global Allergy and Asthma European Network (GA2LEN) Announce … – The Herald | HeraldOnline.com

PPD and Global Allergy and Asthma European Network (GA2LEN) Announce
The Herald | HeraldOnline.com
WILMINGTON, N.C., & BERLIN, Germany — Pharmaceutical Product Development, LLC (PPD) and the Global Allergy and Asthma European Network e.V. (GA2LEN) today announced a strategic alliance in which GA2LEN will provide PPD access to the

and more »

View full post on asthma – Google News

KaloBios Initiates Phase 2 Study with KB003 Humaneered™ Monoclonal … – The Herald | HeraldOnline.com

KaloBios Initiates Phase 2 Study with KB003 Humaneered™ Monoclonal
The Herald | HeraldOnline.com
KaloBios Pharmaceuticals, Inc. today announced that dosing has begun in a randomized, double-blind, placebo-controlled Phase 2 clinical trial of KB003, the company's anti-GM-CSF Humaneered™ monoclonal antibody, in subjects with severe asthma

and more »

View full post on asthma – Google News

American Lung Association of the Upper Midwest And Health Care Service … – The Herald | HeraldOnline.com

American Lung Association of the Upper Midwest And Health Care Service
The Herald | HeraldOnline.com
6, 2012 /PRNewswire-USNewswire/ — The American Lung Association of the Upper Midwest (ALAUM) and Health Care Service Corporation (HCSC) have announced a joint initiative to improve pediatric asthma care to an estimated 480,000 children over the

and more »

View full post on asthma – Google News

Rigel Initiates Phase 2 Clinical Studies with R343 for Asthma and R333 for … – The Herald | HeraldOnline.com

Rigel Initiates Phase 2 Clinical Studies with R343 for Asthma and R333 for
The Herald | HeraldOnline.com
SOUTH SAN FRANCISCO, Calif., Sept. 5, 2012 — /PRNewswire/ — Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that it has commenced Phase 2 clinical studies with two of the company's most advanced proprietary therapeutic product
Rigel Pharma (RIGL) Starts Clinical Studies For Asthma, Discoid LupusiStockAnalyst
Rigel Begins Trial With Advanced Proprietary Therapeutic Product CandidatesNASDAQ

all 13 news articles »

View full post on asthma – Google News

Hidden Toxic Chemicals Linked to Asthma and Birth Defects Found in Children’s … – The Herald | HeraldOnline.com

Hidden Toxic Chemicals Linked to Asthma and Birth Defects Found in Children's
The Herald | HeraldOnline.com
26, 2012 /PRNewswire-USNewswire/ — A brand new report reveals that toxic chemicals linked to asthma and birth defects that are banned in toys were found to be widespread in children's vinyl back-to-school supplies. Seventy-five percent of children's

and more »

View full post on asthma – Google News